Safety and Tolerability of IDO-1 Inhibition in the Prevention of EBV-related Pathology in EBV Negative Kidney Transplant Recipients Receiving an Organ From EBV Positive Donors
Clinical trial NCT07368153 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07368153
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-01
- Primary completion
- 2027-02-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.